These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10131492)

  • 1. A cost comparison of Canadian and U.S. hospital pharmacy departments.
    Weil TP
    Hosp Pharm; 1994 Jan; 29(1):15-7, 20-3. PubMed ID: 10131492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical services in a third-party system: an analysis.
    Donehew GR
    Contemp Pharm Pract; 1981; 4(4):246-52. PubMed ID: 10256900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do Canadian hospitals do it? A comparison of utilization and costs in the United States and Canada.
    Weil TP
    Hosp Top; 1995; 73(1):10-22. PubMed ID: 10142201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the cost of specialty pharmaceuticals.
    Kernich CA; Creighton FA
    Nurs Econ; 2004; 22(5):245-50, 227. PubMed ID: 15586478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital cost of abdominal aortic aneurysm repair in Canada and the United States.
    Brox AC; Filion KB; Zhang X; Pilote L; Obrand D; Haider S; Azoulay A; Eisenberg MJ
    Arch Intern Med; 2003 Nov; 163(20):2500-4. PubMed ID: 14609787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital expenditures in the United States and Canada.
    Redelmeier DA; Fuchs VR
    N Engl J Med; 1993 Mar; 328(11):772-8. PubMed ID: 8437598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health reform--its potential impact on hospital nursing service.
    Weil TP; Stack MC
    Nurs Econ; 1993; 11(4):200-4. PubMed ID: 8232637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of inpatient pharmaceutical services in U.S. hospitals in 1989.
    Bond CA; Pitterle ME; Raehl CL
    Am J Hosp Pharm; 1992 Feb; 49(2):347-67. PubMed ID: 1554000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Battered bottom lines: the impact of eroding pharmaceutical discounts on health-care institutions.
    Palumbo FB; Schondelmeyer SW; Miller DW; Speedie SM
    Am J Hosp Pharm; 1992 May; 49(5):1177-85. PubMed ID: 1595750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of maintaining adequate antidote supplies.
    Bailey B; Bussières JF
    CMAJ; 2001 Nov; 165(11):1467. PubMed ID: 11762566
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug cost increases are generated by the 50 top selling pharmaceuticals.
    Health Care Strateg Manage; 2001 Jun; 19(6):14-5, 1. PubMed ID: 11409091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
    Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
    Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two methods for allocating pharmacy cost per patient case.
    Pink GH; Bolley HB; Cockerill RW
    Am J Hosp Pharm; 1994 May; 51(10):1331-4. PubMed ID: 8085571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors driving costs must figure into reform.
    Coddington D; Keen D; Moore K; Clarke R
    Healthc Financ Manage; 1991 Jul; 45(7):44, 48, 50 passim. PubMed ID: 10145460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost containment for the public health.
    Eastaugh SR
    J Health Care Finance; 2006; 32(3):20-7. PubMed ID: 18975729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the process of medication budget forecasting.
    Vermeulen LC; Marnocha RM; Thielke TS
    Pharm Pract Manag Q; 1998 Apr; 18(1):72-80. PubMed ID: 10177544
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two United States federal Medicare databases.
    Halpern NA; Pastores SM; Thaler HT; Greenstein RJ
    Crit Care Med; 2007 Mar; 35(3):692-9. PubMed ID: 17255850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF (Granulocyte Colony-Stimulating Factor): follow-up and use in a French University hospital.
    Furet I; Closson V; Madelaine I; Faure P
    Can J Hosp Pharm; 1995 Apr; 48(2):90-7. PubMed ID: 10142843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug costs in departments of internal medicine. An analysis of costs for patients and departments].
    Rabøl R; Kolbye A; Andersen SE
    Ugeskr Laeger; 2003 Apr; 165(15):1565-8. PubMed ID: 12715661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.